Display Settings:

Format

Send to:

Choose Destination
    J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):157-65.

    Complementary and alternative medicine use and substitution for conventional therapy by HIV-infected patients.

    Source

    Division of General Internal Medicine and Health Services Research, Department of Medicine, University of California-Los Angeles, 911 Broxton Plaza, Los Angeles, CA 90095-1736, USA. ahsiao@mednet.ucla.edu

    Abstract

    BACKGROUND:

    HIV-infected patients commonly use complementary and alternative medicine (CAM), but it is not known how often CAM is used as a complement or as a substitute for conventional HIV therapy.

    OBJECTIVES:

    To evaluate the prevalence and factors associated with CAM use with potential for adverse effects and CAM substitution for conventional HIV medication.

    DESIGN AND PARTICIPANTS:

    Cross-sectional survey of U.S. national probability sample of HIV-infected patients (2,466 adults) in care from December 1996 to July 1997.

    MAIN OUTCOME VARIABLES:

    Any CAM use, CAM use with potential for adverse effects, and use of CAM as a substitute for conventional HIV therapy. Substitution was defined as replacement of some or all conventional HIV medications with CAM.

    RESULTS:

    Fifty-three percent of patients had recently used at least one type of CAM. One quarter of patients used CAM with the potential for adverse effects, and one-third had not discussed such use with their health care provider. Patients with a greater desire for medical information and involvement in medical decision making and with a negative attitude toward antiretrovirals were more likely to use CAM. Three percent of patients substituted CAM for conventional HIV therapy. They were more likely to desire involvement in medical decision-making (odds ratio, 1.8; 95% confidence interval, 1.0-3.2) and to have a negative attitude toward antiretrovirals (odds ratio, 7.8; 95% confidence interval, 3.0-19.0).

    CONCLUSIONS:

    Physicians should openly ask HIV-infected patients about CAM use to prevent adverse effects and to identify CAM substitution for conventional HIV therapy.

    PMID:
    12794548
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Lippincott Williams & Wilkins
      Write to the Help Desk